Eventually these accumulations increase in the level of IL-17A and contribute to the NASH (nonalcoholic steatohepatitis)-HCC transition and HCC progression [50,51,52]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.